Marcela V. Maus

Marcela V. Maus

Top Cited Scholar 2026
Auto-generated profile, based on publicly available information

Marcela V. Maus

Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts, United States

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in Transplantation and Cellular Therapy
Verified
Journal Article
Open access
DLDaniel W. Lee
Daniel W. Lee
BSBianca D. Santomasso
Bianca D. Santomasso
FLFrederick L Locke
Frederick L Locke
AGArmin Ghobadi
Armin Ghobadi
CTCameron J. Turtle
Cameron J. Turtle
SNSattva S. Neelapu
Sattva S. Neelapu
Chimeric antigen receptor (CAR) T cell therapy is rapidly emerging as one of the most promising therapies for hematologic malignancies. Two CAR T products were recently approved in the United States and Europe for the treatment ofpatients up to age 25years with relapsed or refractory B cell acute lymphoblastic leukemia and/or adults with large B cell lymphoma. Many more CAR T products, as well as other immunotherapies, including various immune cell- and bi-specific antibody-based approaches that function by activation of immune effector cells, are in clinical development for both hematologic and solid tumor malignancies. These therapies are associated with unique toxicities of cytokine release syndrome (CRS) and neurologic toxicity. The assessment and grading of these toxicities vary considerably across clinical trials and across institutions, making it difficult to compare the safety of different products and hindering the ability to develop optimal strategies for management of these toxicities. Moreover, some aspects of these grading systems can be challenging to implement across centers. Therefore, in an effort to harmonize the definitions and grading systems for CRS and neurotoxicity, experts from all aspects of the field met on June 20 and 21, 2018, at a meeting supported by the American Society for Transplantation and Cellular Therapy (ASTCT; formerly American Society for Blood and Marrow Transplantation, ASBMT) in Arlington, VA. Here we report the consensus recommendations of that group and propose new definitions and grading for CRS and neurotoxicity that are objective, easy to apply, and ultimately more accurately categorize the severity of these toxicities. The goal is to provide a uniform consensus grading system for CRS and neurotoxicity associated with immune effector cell therapies, for use across clinical trials and in the postapproval clinical setting.

19 July 2017 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
DODonald M. O’rourke
Donald M. O’rourke
MNMacLean Pancoast Nasrallah
MacLean Pancoast Nasrallah
ADArati Desai
Arati Desai
Jan Joseph MelenhorstJan Joseph Melenhorst
Jan Joseph Melenhorst
KMKeith Mansfield
Keith Mansfield
MMMarcela V. Maus
Marcela V. Maus
A trial of autologous T cells redirected to a specific mutation in glioblastoma patients illustrates mechanisms of resistance.

22 January 2021 in Nature Reviews Cancer
Verified
Journal Article
Closed access
PDF file
RLRebecca C. Larson
Rebecca C. Larson
MMMarcela V. Maus
Marcela V. Maus

18 March 2007 in Nature Medicine
Verified
Journal Article
Closed access
FMFederico Mingozzi
Federico Mingozzi
MMMarcela V Maus
Marcela V Maus
DHDaniel J Hui
Daniel J Hui
DSDenise E Sabatino
Denise E Sabatino
SMSamuel L Murphy
Samuel L Murphy
KHKatherine A High
Katherine A High

11 February 2019 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
BKBenjamin P. Kleinstiver
Benjamin P. Kleinstiver
ASAlexander A. Sousa
Alexander A. Sousa
RWRussell T. Walton
Russell T. Walton
YTY. Esther Tak
Y. Esther Tak
JHJonathan Y. Hsu
Jonathan Y. Hsu
JJJ. Keith Joung
J. Keith Joung

9 July 2018 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
LTLi Tang
Li Tang
YZYiran Zheng
Yiran Zheng
MMMariane Bandeira Melo
Mariane Bandeira Melo
LMLlian Mabardi
Llian Mabardi
ACAna P Castaño
Ana P Castaño
DIDarrell J Irvine
Darrell J Irvine